Now showing items 1-2 of 2

    • Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers 

      Rangachari, Deepa; Yamaguchi, Norihiro; Vanderlaan, Paul A; Folch, Erik E; Mahadevan, Anand; Floyd, Scott R.; Uhlmann, Erik J; Wong, Eric S.; Dahlberg, Suzanne Eleanor; Huberman, Mark S.; Costa, Daniel Botelho (Elsevier BV, 2015)
      Introduction—Brain metastases (BM) are common in non-small-cell lung cancer (NSCLC). However, the baseline incidence and evolution of BM over time in oncogene-driven NSCLCs are seldom reported. In this study, we evaluated ...
    • MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression 

      Awad, Mark Magdi; Oxnard, Geoffrey Raymond; Jackman, David M; Savukoski, Daniel O.; Hall, Dimity; Shivdasani, Priyanka; Heng, Jennifer C.; Dahlberg, Suzanne Eleanor; Janne, Pasi Antero; Verma, Suman; Christensen, James; Hammerman, Peter Seth; Sholl, Lynette Marie (American Society of Clinical Oncology (ASCO), 2016)
      Purpose Non–small-cell lung cancers (NSCLCs) harboring mutations in MET exon 14 and its flanking introns may respond to c-Met inhibitors. We sought to describe the clinical, pathologic, and genomic characteristics of ...